Colesevelam Hydrochloride
"Colesevelam Hydrochloride" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An allylamine derivative that binds BILE ACIDS in the intestine and is used as an ANTICHOLESTEREMIC AGENT in the treatment of HYPERCHOLESTEROLEMIA and HYPERLIPIDEMIAS.
Descriptor ID |
D000069472
|
MeSH Number(s) |
D02.092.050.500 D02.455.326.271.122.100.500
|
Concept/Terms |
GT 31104- GT 31104
- 31104, GT
- GT-31104
- GT31-104
- GT31 104
- GT31104
|
Below are MeSH descriptors whose meaning is more general than "Colesevelam Hydrochloride".
Below are MeSH descriptors whose meaning is more specific than "Colesevelam Hydrochloride".
This graph shows the total number of publications written about "Colesevelam Hydrochloride" by people in this website by year, and whether "Colesevelam Hydrochloride" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 0 | 2 | 2 |
2011 | 0 | 1 | 1 |
2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colesevelam Hydrochloride" by people in Profiles.
-
Type 2 Diabetes Medication Review. Am J Med Sci. 2016 Apr; 351(4):342-55.
-
Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2012 Jan; 14(1):40-6.
-
Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study. Endocr Pract. 2010 Jul-Aug; 16(4):617-28.
-
Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes. Endocr Pract. 2010 Jul-Aug; 16(4):629-40.